Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-005102
Filing Date
2023-02-28
Accepted
2023-02-28 16:15:59
Documents
5
Effectiveness Date
2023-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 sndx-20223-02-s8.htm S-8 145941
2 EX-5.1 sndx-ex5_1.htm EX-5 14154
3 EX-23.1 sndx-ex23_1.htm EX-23 4363
4 EX-FILING FEES sndx-exfiling_fees.htm EX-FILING FEES 65947
5 GRAPHIC img160177385_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-23-005102.txt   272008
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270093 | Film No.: 23685528
SIC: 2834 Pharmaceutical Preparations